Early Stage

98% of vaccines are given with needles. But, we’re changing that!

98% of vaccines are given with needles. But, we’re changing that!


Raised to Date: Raised: $0

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Preferred

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Not Funded
Reporting Date


Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise


Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Alcohol, Tobacco, & Recreational Drugs

Tech Sector


Delavan, Wisconsin

PlantPharm, with a pre-money valuation of $33 million, is raising on WeFunder. The company has created a technology to develop oral vaccines and biologic drugs from organic plants. Through the use of their Platform Technology, costs of vaccines can be lowered and vaccines can be administered without a cold-chain environment and needles. PlantPharm was founded by Robert Britt. The current round of crowdfunding has a minimum target of $100,002. The technology of PlantPharm has received several grants from the U.S. National Institute of Health R&D, and FDA has authorized a second clinical trial on its first ever vaccine.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
PlantPharm on Wefunder
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $33,000,000
Price per Share: $1.50

Follow company

Follow PlantPharm on Wefunder

Buy PlantPharm's Deal Report

Warning: according to the close date for this deal, PlantPharm may no longer be accepting investments.

PlantPharm Deal Report

Get KingsCrowd’s comprehensive report on PlantPharm including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether PlantPharm is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the PlantPharm deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge